메뉴 건너뛰기
Lung Cancer
Volumn 54, Issue 2, 2006, Pages 265-266
EGFR genotyping in pleural fluid specimens in NSCLC patients
Author keywords

[No Author keywords available]
Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; NUCLEOTIDE;
EID: 33751339805     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.07.003     Document Type: Letter
Times cited : (3)
References (6)
  • 1
    • 21144457929 scopus 로고    scopus 로고
    • Clinically meaningful improvement in symptom and quality of life for patients with non-small cell lung cancer receiving gefitinib in a randomized controlled trial
    • Cella D., Herbst R.S., Lynch T.J., Prager D., Belani C.P., Schiller J.H., et al. Clinically meaningful improvement in symptom and quality of life for patients with non-small cell lung cancer receiving gefitinib in a randomized controlled trial. J Clin Oncol 23 13 (2005) 2946-2954
    • (2005) J Clin Oncol , vol.23 , Issue.13 , pp. 2946-2954
    • Cella, D.1    Herbst, R.S.2    Lynch, T.J.3    Prager, D.4    Belani, C.P.5    Schiller, J.H.6
  • 2
    • 4444344330 scopus 로고    scopus 로고
    • EGF receptor gene mutations are common in lung cancer from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib
    • Pao W., Miller V., Zakowski M., Doherty J., Politi K., Sarkaria I., et al. EGF receptor gene mutations are common in lung cancer from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. PNAS 101 36 (2004) 13306-13311
    • (2004) PNAS , vol.101 , Issue.36 , pp. 13306-13311
    • Pao, W.1    Miller, V.2    Zakowski, M.3    Doherty, J.4    Politi, K.5    Sarkaria, I.6
  • 3
    • 2342471392 scopus 로고    scopus 로고
    • Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
    • Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350 21 (2004) 2129-2139
    • (2004) N Engl J Med , vol.350 , Issue.21 , pp. 2129-2139
    • Lynch, T.J.1    Bell, D.W.2    Sordella, R.3    Gurubhagavatula, S.4    Okimoto, R.A.5    Brannigan, B.W.6
  • 4
    • 2342624080 scopus 로고    scopus 로고
    • EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy
    • Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304 5676 (2004) 1497-1500
    • (2004) Science , vol.304 , Issue.5676 , pp. 1497-1500
    • Paez, J.G.1    Janne, P.A.2    Lee, J.C.3    Tracy, S.4    Greulich, H.5    Gabriel, S.6
  • 5
    • 0023298056 scopus 로고
    • Cytologic detection of malignancy in pleural effusion: a review of 5255 samples from 3811 patients
    • Hsu C. Cytologic detection of malignancy in pleural effusion: a review of 5255 samples from 3811 patients. Diagn Cytopathol 3 1 (1987) 8-12
    • (1987) Diagn Cytopathol , vol.3 , Issue.1 , pp. 8-12
    • Hsu, C.1
  • 6
    • 0004207479 scopus 로고    scopus 로고
    • Lippincott Wiilliams & Wilkins, Baltimore, MD p. 108-34
    • Light R.W. Pleural diseases. 4th ed. (2001), Lippincott Wiilliams & Wilkins, Baltimore, MD p. 108-34
    • (2001) Pleural diseases. 4th ed.
    • Light, R.W.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.